Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
100%(2 trials)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_1
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (33.3%)
N/A2 (66.7%)

Trials by Status

unknown133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_1

Prevention Trial Assessing Paper-Tape in Endurance Distances (PreTAPED)

NCT01120808
completednot_applicable

Prevention Trial Assessing Paper-Tape in Endurance Distances II (Pre-TAPED II)

NCT01945112
unknownnot_applicable

Prevention of Hypertrophic Scars or Keloids

NCT00849004

Clinical Trials (3)

Showing 3 of 3 trials
NCT01120808Phase 1

Prevention Trial Assessing Paper-Tape in Endurance Distances (PreTAPED)

Completed
NCT01945112Not Applicable

Prevention Trial Assessing Paper-Tape in Endurance Distances II (Pre-TAPED II)

Completed
NCT00849004Not Applicable

Prevention of Hypertrophic Scars or Keloids

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3